Got an email from Replicor

[mer971]

Trial will start very soon in Europe. It Is expected elemination of Hbsag within 10 weeks and antibodies production rapidly after. Cure is  here,clear and soon !

[stef2011]

none if used mono, and both too little data to say

one thing is certain myrcludex mono is of very little use to clear hbv

[NewlyDiscovered]

Which is your bet as the more potent drug of the two?

Thanks.

[stef2011]

they may register in europe instead of US, it is cheaper and they can register as HDV cure.since hdv has not one single therapy that works they can have fast and cheap registration as orphan drug

i guess myrcludex is doing the same thing to get registration, marketing of the drug will follow registration

[makeadifferencenow]

I will be seeing the head of Gastro at my hospital next week if no one has any info before then I will find out what the conditions apply and post on here. Its goooooood news. Lets hope nothing dodgy happens or a petition might be on the cards :)

Does anyone know how a drug gets the status "exceptional circumstance" ??????

[StephenCastlecrag]

We have only one source of news - Christine Kukka from HBVadovcate. Yes, I think it will involve combining with the use of NA such as Entecavir or Tenofovir, just like ARC520.

[NewlyDiscovered]

Stephen

What do you know about this European trial? What does it seek to establish? Is it a trial on nuc + inf + replicor as mentioned above?

Thanks